Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

AMR: EU ban on group use of prophylactics confirmed
Georgina Crayford, NPA’s senior policy advisor, said the changes could have major implications for the way pig health is managed.

NPA says there could be major implications for pig health

An EU ban on the prophylactic use of antibiotics in groups of animals has been confirmed.

Under the revised EU Regulation on Veterinary Medicinal Products, which comes into force in 2021, veterinary surgeons will only be able to prescribe prophylactic antibiotics for administration to individual animals.

The regulation states: ‘Antimicrobial medicinal products shall not be used for prophylaxis unless, in exceptional cases for the administration to an individual animal or a restricted number of animals when the risk of an infection or of an infectious disease is very high and the consequences are likely to be severe.

‘In such cases the use of antibiotic medicinal products for prophylaxis shall be limited to the administration to individual animal only, under the conditions laid down in the first sentence.’

In a recent letter to the UK’s chief veterinary officer, the National Pig Association and Pig Veterinary Society raised serious concerns about the plans.

Whilst agreeing that prophylaxis should only be deployed in ‘exceptional cases’, the two organisations warned that limiting this to individual animals is ‘unnecessary and risks seriously impacting pig health’.

Georgina Crayford, NPA’s senior policy advisor, said the changes could have major implications for the way pig health is managed.

“The NPA is working with RUMA, PVS and others to fully understand how this piece of legislation will be interpreted and what the implications will be for disease management in pigs,” she explained.

“We fully agree, of course, that prophylaxis should not be deployed routinely and only in exceptional circumstances. But we see no logic in prohibiting its use in groups of pigs, when it is deemed necessary for pigs’ health.”

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.